| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Total revenue | $126.0M-0.8% | $127.0M-28.2% | $177.0M-59.8% | $440.0M+621.3% | $61.0M-17.6% | $74.0M-100.0% | $48.00T | — |
| Cost of sales | $868.0M-40.7% | $1.46B-68.8% | $4.69B-13.3% | $5.42B+107.0% | $2.62B+32612.5% | $8.0M | $0 | $0 |
| Research and development | $3.13B-31.1% | $4.54B-6.2% | $4.84B+47.0% | $3.29B+65.5% | $1.99B+45.3% | $1.37B-100.0% | $496.00T+109231272.3% | $454.1M |
| Selling, general and administrative | $1.02B-13.3% | $1.17B-24.2% | $1.55B+36.8% | $1.13B+99.6% | $567.0M+201.6% | $188.0M-100.0% | $110.00T+116708298.8% | $94.3M |
| Total operating expenses | $5.02B-30.1% | $7.18B-35.2% | $11.09B+12.6% | $9.84B+90.2% | $5.17B+230.5% | $1.57B-100.0% | $606.00T+110516483.0% | $548.3M |
| Loss from operations | -$3.07B+22.1% | -$3.94B+6.9% | -$4.24B-145.0% | $9.42B-29.2% | $13.30B+1842.6% | -$763.0M+100.0% | -$546.00T-132118196.7% | -$413.3M |
| Interest income | $314.0M-26.1% | $425.0M+1.0% | $421.0M+110.5% | $200.0M+1011.1% | $18.0M-28.0% | $25.0M-100.0% | $39.00T+144321403.9% | $27.0M |
| Other expense, net | -$8.0M+90.8% | -$87.0M+29.8% | -$124.0M-175.6% | -$45.0M-55.2% | -$29.0M-383.3% | -$6.0M+100.0% | -$8.00T-435967402.5% | $1.8M |
| Loss before income taxes | -$2.77B+23.3% | -$3.61B+8.5% | -$3.94B-141.2% | $9.57B-27.9% | $13.29B+1885.6% | -$744.0M+100.0% | -$515.00T | — |
| Provision for (benefit from) tax provision | $54.0M+217.4% | -$46.0M-106.0% | $772.0M-36.4% | $1.21B+12.0% | $1.08B+36000.0% | $3.0M+100.0% | -$1.00T-306748566.3% | $326K |
| Net loss | -$2.82B+20.8% | -$3.56B+24.5% | -$4.71B-156.4% | $8.36B-31.5% | $12.20B+1733.5% | -$747.0M+100.0% | -$514.00T-133598698.1% | -$384.7M |
| Basic (in usd per share) | -$7260.00+21.8% | -$9280.00+24.7% | -$12330.00-100.1% | $21260000.00-29.9% | $30310000.00+1646.4% | -$1960000.00-26.5% | -$1550000.00 | — |
| Diluted (in usd per share) | -$7260.00+21.8% | -$9280.00+24.7% | -$12330.00-100.1% | $20120000.00-28.9% | $28290000.00+1543.4% | -$1960000.00-26.5% | -$1550000.00 | — |
| Basic (in shares) | 389.0M+1.3% | 384.0M+0.5% | 382.0M-3.0% | 394.0M-2.2% | 403.0M+5.8% | 381.0M+15.1% | 331.0M | — |
| Diluted (in shares) | 389.0M+1.3% | 384.0M+0.5% | 382.0M-8.2% | 416.0M-3.5% | 431.0M+13.1% | 381.0M+15.1% | 331.0M | — |
| Net product sales | ||||||||
| Other revenue | ||||||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.